NOREPINEPHRINE\NOREPINEPHRINE: 1,055 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,055
Total FAERS Reports
296 (28.1%)
Deaths Reported
553
Hospitalizations
1,055
As Primary/Secondary Suspect
297
Life-Threatening
53
Disabilities
Active Ingredient: NOREPINEPHRINE\NOREPINEPHRINE BITARTRATE ·
First Report: 20000916 · Latest Report: 20241204
What Are the Most Common NOREPINEPHRINE\NOREPINEPHRINE Side Effects?
#1 Most Reported
Drug ineffective
322 reports (30.5%)
#2 Most Reported
Condition aggravated
112 reports (10.6%)
#3 Most Reported
Off label use
97 reports (9.2%)
All NOREPINEPHRINE\NOREPINEPHRINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 322 | 30.5% | 127 | 221 |
| Condition aggravated | 112 | 10.6% | 67 | 77 |
| Off label use | 97 | 9.2% | 54 | 71 |
| Hypotension | 80 | 7.6% | 19 | 46 |
| Cardiogenic shock | 70 | 6.6% | 43 | 58 |
| Multiple organ dysfunction syndrome | 70 | 6.6% | 68 | 54 |
| Sepsis | 44 | 4.2% | 42 | 39 |
| Shock | 43 | 4.1% | 15 | 26 |
| Anaemia | 42 | 4.0% | 35 | 39 |
| Death | 42 | 4.0% | 42 | 24 |
| Ventricular fibrillation | 42 | 4.0% | 38 | 36 |
| Product use in unapproved indication | 40 | 3.8% | 24 | 26 |
| Dyspnoea | 39 | 3.7% | 30 | 34 |
| Hyponatraemia | 37 | 3.5% | 36 | 34 |
| Nausea | 37 | 3.5% | 30 | 34 |
| Vomiting | 37 | 3.5% | 34 | 34 |
| Abdominal distension | 36 | 3.4% | 36 | 34 |
| Ascites | 36 | 3.4% | 36 | 32 |
| Acute kidney injury | 35 | 3.3% | 17 | 27 |
| Appendicitis | 35 | 3.3% | 35 | 32 |
Who Reports NOREPINEPHRINE\NOREPINEPHRINE Side Effects? Age & Gender Data
Gender: 44.3% female, 55.7% male. Average age: 56.9 years. Most reports from: US. View detailed demographics →
Is NOREPINEPHRINE\NOREPINEPHRINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 11 | 0 | 0 |
| 2006 | 2 | 0 | 0 |
| 2010 | 2 | 2 | 1 |
| 2013 | 2 | 2 | 2 |
| 2014 | 15 | 4 | 1 |
| 2015 | 23 | 5 | 15 |
| 2016 | 17 | 3 | 7 |
| 2017 | 11 | 3 | 3 |
| 2018 | 14 | 2 | 9 |
| 2019 | 40 | 5 | 21 |
| 2020 | 43 | 20 | 19 |
| 2021 | 25 | 3 | 17 |
| 2022 | 11 | 2 | 7 |
| 2023 | 47 | 26 | 11 |
| 2024 | 95 | 9 | 37 |
What Is NOREPINEPHRINE\NOREPINEPHRINE Used For?
| Indication | Reports |
|---|---|
| Hypotension | 202 |
| Product used for unknown indication | 191 |
| Septic shock | 83 |
| Haemodynamic instability | 52 |
| Shock | 52 |
| Stress | 43 |
| Cardiogenic shock | 36 |
| Vasopressive therapy | 27 |
| Anaesthesia | 18 |
| Circulatory collapse | 17 |
NOREPINEPHRINE\NOREPINEPHRINE vs Alternatives: Which Is Safer?
NOREPINEPHRINE\NOREPINEPHRINE vs NORETHINDRONE
NOREPINEPHRINE\NOREPINEPHRINE vs NORFLOXACIN
NOREPINEPHRINE\NOREPINEPHRINE vs NORGESTREL
NOREPINEPHRINE\NOREPINEPHRINE vs NORTRIPTYLINE
NOREPINEPHRINE\NOREPINEPHRINE vs NORVASC
NOREPINEPHRINE\NOREPINEPHRINE vs NORVIR
NOREPINEPHRINE\NOREPINEPHRINE vs NOSCAPINE
NOREPINEPHRINE\NOREPINEPHRINE vs NOVOLOG
NOREPINEPHRINE\NOREPINEPHRINE vs NPLATE
NOREPINEPHRINE\NOREPINEPHRINE vs NUSINERSEN
Official FDA Label for NOREPINEPHRINE\NOREPINEPHRINE
Official prescribing information from the FDA-approved drug label.